4.5 Article

Extensive functional comparisons between chimeric antigen receptors and T cell receptors highlight fundamental similarities

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Re-examination of MAGE-A3 as a T-cell Therapeutic Target

Aaron D. Martin et al.

Summary: The study suggests that the previously hypothesized MAGE-A12 may not be the primary source of neurotoxicity, and an alternative related peptide, EPS8L2, may be more likely responsible. These findings provide evidence for reconsidering MAGE-A3 as a cancer target.

JOURNAL OF IMMUNOTHERAPY (2021)

Article Biochemistry & Molecular Biology

TCR-engineered T cells targeting E7 for patients with metastatic HPV-associated epithelial cancers

Nisha B. Nagarsheth et al.

Summary: In a first-in-human phase 1 trial, T cells targeting HPV-16 E7 showed promising results in treating metastatic epithelial cancers, with objective clinical responses observed in 6 out of 12 patients. This suggests that genetically engineered T cell therapy may be effective in treating common carcinomas, but further studies are needed to understand the resistance mechanisms in advanced epithelial cancer.

NATURE MEDICINE (2021)

Article Oncology

Potent, Selective CARs as Potential T-Cell Therapeutics for HPV-positive Cancers

Xueyin Wang et al.

Summary: Future T-cell therapies may continue to use T-cell receptors (TCRs) and chimeric antigen receptors (CARs), each with different advantages and challenges in sensitivity and function. Through a combination of high-throughput binding screens and low-throughput functional assays, CARs can exhibit activity comparable to clinical TCRs in vitro.

JOURNAL OF IMMUNOTHERAPY (2021)

Review Oncology

T-Cell Receptor Mimic Antibodies for Cancer Immunotherapy

Zhijian Duan et al.

Summary: Antibody-based immunotherapies have shown efficacy in cancer treatment, but their targets are limited. Research has shown that short peptides from intracellular targets could be potential immunotherapy targets. TCRm antibodies are a promising new direction, and future clinical studies will help further understand their mechanisms of action.

MOLECULAR CANCER THERAPEUTICS (2021)

Review Oncology

Current issues and perspectives in PD-1 blockade cancer immunotherapy

Kenji Chamoto et al.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2020)

Article Immunology

Inefficient CAR-proximal signaling blunts antigen sensitivity

Venugopal Gudipati et al.

NATURE IMMUNOLOGY (2020)

Article Biochemistry & Molecular Biology

Structure-function relationships of chimeric antigen receptors in acute T cell responses to antigen

Han Xu et al.

MOLECULAR IMMUNOLOGY (2020)

Article Multidisciplinary Sciences

Synthetic TRuC receptors engaging the complete T cell receptor for potent anti-tumor response

Patrick A. Baeuerle et al.

NATURE COMMUNICATIONS (2019)

Article Multidisciplinary Sciences

Structural basis of assembly of the human T cell receptor-CD3 complex

De Dong et al.

NATURE (2019)

Review Immunology

Engineered T Cell Therapy for Cancer in the Clinic

Lijun Zhao et al.

FRONTIERS IN IMMUNOLOGY (2019)

Review Biochemistry & Molecular Biology

TCR Signaling: Mechanisms of Initiation and Propagation

Adam H. Courtney et al.

TRENDS IN BIOCHEMICAL SCIENCES (2018)

Article Medicine, Research & Experimental

A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigens

Aaron Y. Chang et al.

JOURNAL OF CLINICAL INVESTIGATION (2017)

Article Multidisciplinary Sciences

Rescue of exhausted CD8 T cells by PD-1-targeted therapies is CD28-dependent

Alice O. Kamphorst et al.

SCIENCE (2017)

Review Oncology

T cell receptor mimic antibodies for cancer therapy

Leonid Dubrovsky et al.

ONCOIMMUNOLOGY (2016)

Article Biochemistry & Molecular Biology

Structure of a TCR-Mimic Antibody with Target Predicts Pharmacogenetics

Niloufar Ataie et al.

JOURNAL OF MOLECULAR BIOLOGY (2016)

Review Pharmacology & Pharmacy

Adoptive T Cell Therapies: A Comparison of T Cell Receptors and Chimeric Antigen Receptors

Daniel T. Harris et al.

TRENDS IN PHARMACOLOGICAL SCIENCES (2016)

Review Immunology

Emerging targets in cancer immunotherapy: beyond CTLA-4 and PD-1

Amer Assal et al.

IMMUNOTHERAPY (2015)

Article Biochemistry & Molecular Biology

4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors

Adrienne H. Long et al.

NATURE MEDICINE (2015)

Article Biochemical Research Methods

Leukopak PBMC sample processing for preparing quality control material to support proficiency testing programs

Ambrosia Garcia et al.

JOURNAL OF IMMUNOLOGICAL METHODS (2014)

Article Oncology

Cancer Regression and Neurological Toxicity Following Anti-MAGE-A3 TCR Gene Therapy

Richard A. Morgan et al.

JOURNAL OF IMMUNOTHERAPY (2013)

Article Immunology

An αβ T Cell Receptor Structure at 2.5 Å and Its Orientation in the TCR-MHC Complex

K. Christopher Garcia et al.

JOURNAL OF IMMUNOLOGY (2010)

Review Immunology

Costimulatory and coinhibitory receptors in anti-tumor immunity

Gregory Driessens et al.

IMMUNOLOGICAL REVIEWS (2009)

Article Biotechnology & Applied Microbiology

Directed evolution of human T-cell receptors with picomolar affinities by phage display

Y Li et al.

NATURE BIOTECHNOLOGY (2005)

Article Immunology

Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function

R Zeng et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2005)

Article Immunology

PD-1 inhibits antiviral immunity at the effector phase in the liver

YH Iwai et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2003)